Grasshopper House

Grasshopper House is a SAMHSA-registered addiction-treatment facility in Malibu, CA. The facility offers a continuum of care across multiple levels — Detox, Inpatient, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Grasshopper House

The facility offers a continuum of care across multiple levels — Detox, Inpatient, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

Grasshopper House operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Specialty programming

The facility's documented specialty programming includes: Adult women, Adult men, Clients with co-occurring mental and substance use disorders. Evaluating specialty capacity requires asking specifically: what clinicians deliver the specialty content, with what credentials, for how many hours per week. Marketing designation without documented clinical infrastructure is a recognized pattern worth filtering out.

Before you call

Three pre-admission questions for Grasshopper House: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.